Compass Pathways Q3 Net Losses Narrow; Shares Advance Pre-Bell

09:01 AM EST, 11/03/2026 (MT Newswires) -- Compass Pathways (CMPS) reported a Q3 net loss Tuesday of $0.31 per diluted share, narrowing from a loss of $1.44 a year earlier. Analysts polled by FactSet expected losses of $0.36. The company reported no Q3 revenue, the same as a year earlier. The biopharmaceutical company reported cash and cash equivalents of $444 million as of Sept. 30, up from $149.6 million as of Dec. 31, expected to be sufficient to fund operating expenses and capital expenditure requirements into 2028. Shares of the company were up more than 10% in recent Tuesday premarket activity.